Trial Profile
ENDEAVOR-JAPAN
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Jul 2006
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Registrational; Therapeutic Use
- Acronyms ENDEAVOR-JAPAN
- 12 Jul 2006 New trial record.